2 results match your criteria: "Maryland dNorthwestern University[Affiliation]"
Neurocognition with maraviroc compared with tenofovir in HIV.
AIDS
September 2016
aUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina bHarvard University, Boston, Massachusetts cJohns Hopkins Hospital, Baltimore, Maryland dNorthwestern University, Chicago, Illinois eFrontier Science & Technology, Amherst, New York, USA.
Objective: The objective was to determine whether maraviroc (MVC) has unique neurocognitive benefits in the context of initial antiretroviral therapy (ART).
Design: Randomized, double-blind, placebo-controlled, 48-week trial.
Setting: Participants were enrolled in US AIDS Clinical Trials Group clinical trial sites.
Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.
AIDS
July 2014
aJohns Hopkins University School of Medicine, Baltimore, Maryland bLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California cJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland dNorthwestern University, Chicago, Illinois eUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA. *Michael Brener and Kerunne Ketlogetswe contributed equally to this work.
Objective: Cytokines released by epicardial fat are implicated in the pathogenesis of atherosclerosis. HIV infection and antiretroviral therapy have been associated with changes in body fat distribution and coronary artery disease. We sought to determine whether HIV infection is associated with greater epicardial fat and whether epicardial fat is associated with subclinical coronary atherosclerosis.
View Article and Find Full Text PDF